The total cellular p185 HER-2/neu protein (p185) content was measured by ELISA in 346 invasive primary breast cancers, and the results were compared with those of estrogen (ER) and progesterone (PR) receptors, pS2 and Cathepsin D (Cat D) content. At a cut-off level of 260 fmol/mg protein, 53 of the
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer
β Scribed by Andrea S. Lukes; Matthew F. Kohler; Carl F. Pieper; Billie J. Kerns; Rex Bentley; Gustavo C. Rodriguez; John T. Soper; Daniel L. Clarke-Pearson; Robert C. Bast Jr.; Andrew Berchuck
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 554 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In order to determine retrospectively the impact of some cytometric and immunohistochemical parameters on the overall survival of gastric cancer patients treated with surgery alone, paraffin-embedded tumor samples from 137 gastric carcinoma patients undergoing curative resection from 1987-1993 were
## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly